Long-term viral brain-derived neurotrophic factor delivery promotes spasticity in rats with a cervical spinal cord hemisection

Frontiers in Neurology

Volumn 4 NOV, Issue , 2013, Pages

  Fouad, Karim ^a   Bennett, David J ^a   Vavrek, Romana ^a   Blesch, Armin ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BDNF; Combined treatment; EMG; Spinal cord injury; TrkB Fc

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PARVOVIRUS VECTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CERVICAL SPINAL CORD; CONTROLLED STUDY; CONVALESCENCE; ELECTROMYOGRAPHY; FEMALE; FORELIMB; GENE OVEREXPRESSION; GRIP STRENGTH; HEAT SENSATION; JOINT MOBILITY; LEG MOVEMENT; NERVE CELL STIMULATION; NONHUMAN; RANGE OF MOTION; RAT; SPASTICITY; SPINAL CORD HEMISECTION; VIRAL GENE DELIVERY SYSTEM; WEIGHT REDUCTION;

EID: 84889662375     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00187     Document Type: Article

References (50)

1. Gervasi NM, Kwok JC, Fawcett JW. Role of extracellular factors in axon regeneration in the CNS: implications for therapy. Regen Med (2008) 6:907-23. doi: 10.2217/17460751.3.6.907
2. Coumans JV, Lin TT, Dai HN, MacArthur L, McAtee M, Nash C, et al. Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. J Neurosci (2001) 21(23):9334-44.
3. Fouad K, Schnell L, Bunge MB, Schwab ME, Liebscher T, Pearse DD. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci (2005) 25(5):1169-78. doi:10.1523/JNEUROSCI.3562-04.2005
4. Houle JD, Tom VJ, Mayes D, Wagoner G, Phillips N, Silver J. Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci (2006) 26(28):7405-15. doi:10.1523/JNEUROSCI.1166-06.2006
5. Kadoya K, Tsukada S, Lu P, Coppola G, Geschwind D, Filbin MT, et al. Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron (2009) 64(2):165-72. doi:10.1016/j.neuron.2009.09.016
6. Bretzner F, Liu J, Currie E, Roskams AJ, Tetzlaff W. Undesired effects of a combinatorial treatment for spinal cord injury-transplantation of olfactory ensheathing cells and BDNF infusion to the red nucleus. Eur J Neurosci (2008) 28(9):1795-807. doi:10.1111/j.1460-9568.2008.06462.x
7. García-Alías G, Barkhuysen S, Buckle M, Fawcett JW. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat Neurosci (2009) 12(9):1145-51. doi:10.1038/nn.2377
8. Weishaupt N, Blesch A, Fouad K. BDNF: the career of a multifaceted neurotrophin in spinal cord injury. Exp Neurol (2012) 238(2):254-64. doi:10.1016/j.expneurol.2012.09.001
9. Bamber NI, Li H, Lu X, Oudega M, Aebischer P, Xu XM. Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci (2001) 2:257-68. doi:10.1046/j.1460-9568.2001.01387.x
10. Li C, Zhang X, Cao R, Yu B, Liang H, Zhou M, et al. Allografts of the acellular sciatic nerve and brain-derived neurotrophic factor repair spinal cord injury in adult rats. PLoS One (2012) 7(8):e42813. doi:10.1371/journal.pone.0042813
11. Lu P, Blesch A, Graham L, Wang Y, Samara R, Banos K, et al. Motor axonal regeneration after partial and complete spinal cord transection. J Neurosci (2012) 32(24):8208-18. doi:10.1523/JNEUROSCI.0308-12.2012
12. Lu P, Blesch A, Tuszynski MH. Neurotrophism without neurotropism: BDNF promotes survival but not growth of lesioned corticospinal neurons. J Comp Neurol (2001) 436(4):456-70. doi:10.1002/cne.1080
13. Grill RJ, Blesch A, Tuszynski MH. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp Neurol (1997) 148(2):444-52. doi:10.1006/exnr.1997.6704
14. Blesch A, Tuszynski MH. Transient growth factor delivery sustains regenerated axons after spinal cord injury. J Neurosci (2007) 27(39):10535-45. doi:10.1523/JNEUROSCI.1903-07.2007
15. Taylor L, Jones L, Tuszynski MH, Blesch A. Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord. J Neurosci (2006) 26(38):9713-21. doi:10.1523/JNEUROSCI.0734-06.2006
16. Nikulina E, Tidwell JL, Dai HN, Bregman BS, Filbin MT. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc Natl Acad Sci U S A (2004) 101(23):8786-90. doi:10.1073/pnas.0402595101
17. Krajacic A, Ghosh M, Puentes R, Pearse DD, Fouad K. Advantages of delaying the onset of rehabilitative reaching training in rats with incomplete spinal cord injury. Eur J Neurosci (2009) 29(3):641-51. doi:10.1111/j.1460-9568.2008.06600.x
18. Whishaw IQ, Pellis SM, Gorny B, Kolb B, Tetzlaff W. Proximal and distal impairments in rat forelimb use in reaching follow unilateral pyramidal tract lesions. Behav Brain Res (1993) 56(1):59-76. doi:10.1016/0166-4328(93)90022-I
19. Martinez M, Brezun JM, Bonnier L, Xerri C. A new rating scale for open-field evaluation of behavioral recovery after cervical spinal cord injury in rats. J Neurotrauma (2009) 26(7):1043-53. doi:10.1089/neu.2008.0717
20. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 32(1):77-88. doi:10.1016/0304-3959(88)90026-7
21. Kerr BJ, Bradbury EJ, Bennett DL, Trivedi PM, Dassan P, French J, et al. Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci (1999) 19(12):5138-48.
22. Bariohay B, Roux J, Tardivel C, Trouslard J, Jean A, Lebrun B. Brain-derived neurotrophic factor/tropomyosin-related kinase receptor type B signaling is a downstream effector of the brainstem melanocortin system in food intake control. Endocrinology (2009) 150(6):2646-53. doi:10.1210/en.2008-1184
23. Fouad K, Vavrek R, Cho S. A TrkB antibody agonist promotes plasticity following cervical spinal cord injury in adult rats. J Neurotrauma (2010). doi:10.1089/neu.2009.1116
24. Kobayashi NR, Fan DP, Giehl KM, Bedard AM, Wiegand SJ, Tetzlaff W. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. J Neurosci (1997) 17(24):9583-95.
25. McTigue DM, Horner PJ, Stokes BT, Gage FH. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci (1998) 18(14):5354-65.
26. Jakeman LB, Wei P, Guan Z, Stokes BT. Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury. Exp Neurol (1994) 154(1):170-84. doi:10.1006/exnr.1998.6924
27. Liu Y, Kim D, Himes BT, Chow SY, Schallert T, Murray M, et al. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci (1999) 19(11):4370-87.
28. Hiebert GW, Khodarahmi K, McGraw J, Steeves JD, Tetzlaff W. Brain-derived neurotrophic factor applied to the motor cortex promotes sprouting of corticospinal fibers but not regeneration into a peripheral nerve transplant. J Neurosci Res (2002) 69(2):160-8. doi:10.1002/jnr.10275
29. Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol (2005) 20191(2):344-60. doi:10.1016/j.expneurol.2004.09.018
30. Mantilla CB, Gransee HM, Zhan WZ, Sieck GC. Motoneuron BDNF/TrkB signaling enhances functional recovery after cervical spinal cord injury. Exp Neurol (2013) 247:101-9. doi:10.1016/j.expneurol.2013.04.002
31. Boulenguez P, Liabeuf S, Bos R, Bras H, Jean-Xavier C, Brocard C, et al. Down-regulation of the potassium-chloride co-transporter KCC2 contributes to spasticity after spinal cord injury. Nat Med (2010) 16(3):302-7. doi:10.1038/nm.2107
32. Kafitz KW, Rose CR, Thoenen H, Konnerth A. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature (1999) 401(6756):918-21. doi:10.1038/44847
33. Constandil L, Aguilera R, Goich M, Hernández A, Alvarez P, Infante C, et al. Involvement of spinal cord BDNF in the generation and maintenance of chronic neuropathic pain in rats. Brain Res Bull (2011) 86(5-6):454-9. doi:10.1016/j.brainresbull.2011.08.008
34. Biggs JE, Lu VB, Stebbing MJ, Balasubramanyan S, Smith PA. Is BDNF sufficient for information transfer between microglia and dorsal horn neurons during the onset of central sensitization? Mol Pain (2010) 6:44. doi:10.1186/1744-8069-6-44
35. Thompson CK, Jayaraman A, Kinnaird C, Hornby TG. Methods to quantify pharmacologically induced alterations in motor function in human incomplete SCI. J Vis Exp (2011) 50:e2148. doi:10.3791/2148
36. Wainberg M, Barbeau H, Gauthier S. The effects of cyproheptadine on locomotion and on spasticity in patients with spinal cord injuries. J Neurol Neurosurg Psychiatry (1990) 53(9):754-63. doi:10.1136/jnnp.53.9.754
37. Botte MJ, Nickel VL, Akeson WH. Spasticity and contracture. Physiologic aspects of formation. Clin Orthop Relat Res (1988) 233:7-18.
38. Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol (2008) 209:378-88. doi:10.1016/j.expneurol.2007.06.009
39. Gulino R, Lombardo SA, Casavona A, Leanza G, Perciavalle V. Level of brain-derived neurotrophic factor and neurotrophin-4 in lumbar motoneurons after low-thoracic spinal cord hemisection. Brain Res (2004) 1013:174-81. doi:10.1016/j.brainres.2004.03.055
40. Ikeda O, Murakami M, Ino H, Yamazaki M, Nemoto T, Koda M, et al. Acute up-regulation of brain-derived neurotrophic factor expression resulting from experimentally induced injury in the rat spinal cord. Acta Neuropathol (2001) 102:239-45.
41. Boyce VS, Park J, Gage FH, Mendell LM. Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats. Eur J Neurosci (2012) 35(2):221-32. doi:10.1111/j.1460-9568.2011.07950.x
42. Gonzales M, Collins WF III. Modulation of motoneuron excitability by brain-derived neurotrophic factor. J Neurophysiol (1997) 77:502-6.
43. Carvalho AL, Caldeira MV, Santos SD, Duarte CB. Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br J Pharmacol (2007) 153(Suppl 1):S310-24. doi:10.1038/sj.bjp.0707509
44. Blum R, Konnerth A. Neurotrophin-mediated rapid signalling in the central nervous system: mechanisms and functions. Physiology (2005) 20:70-8. doi:10.1152/physiol.00042.2004
45. Rivera C, Voipio J, Thomas-Crusells J, Li H, Emri Z, Sipilä S, et al. Mechanism of activity-dependent downregulation of the neuron-specific K-Cl cotransporter KCC2. J Neurosci (2004) 24(19):4683-91. doi:10.1523/JNEUROSCI.5265-03.2004
46. Vicario-Abejon C, Collin C, McKay RD, Segal M. Neurotrophins induce formation of functional excitatory and inhibitory synapses between cultured hippocampal neurons. J Neurosci (1998) 18:7256-71.
47. Rutherford LC, Nelson SB, Turrigiano GG. BDNF has opposite effects on the quantal amplitude of pyramidal neuron and interneuron excitatory synapses. Neuron (1998) 21(3):521-30. doi:10.1016/S0896-6273(00)80563-2
48. Bolton MM, Pittman AJ, Lo DC. Brain-derived neurotrophic factor differentially regulates excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci (2000) 20(9):3221-32.
49. Murray KC, Nakae A, Stephens MJ, Rank M, D'Amico J, Harvey PJ, et al. Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors. Nat Med (2010) 16(6):694-700. doi:10.1038/nm.2160
50. Hounsgaard J, Hultborn H, Jespersen B, Kiehn O. Bistability of a-motoneurones in the decerebrate cat and in the acute spinal cat after intravenous 5-hydroxytryptophan. J Physiol (1988) 405:345-67.